A Centralized Platform study for Functional High Risk Multiple Myeloma (ACTRN12625000429459)
ZEPFHR-MM
This trial is Currently recruiting
Registration number ACTRN12625000429459
Program & service
This trial is being run with the Cancer service, and as part of the Haematology program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principle investigator
Professor Andrew Spencer
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR